The study rests on a large-scale telephone survey conducted by Spain’s Centro de Investigaciones Sociológicas between 6 and 15 February 2025, the first national survey the institute has devoted entirely to artificial intelligence. Interviews were completed in 1,131 municipalities across all 50 provinces, with stratified sampling by region and municipality size to ensure the sample mirrors the adult population. The crucial question asked respondents to rate, on a scale from 1 to 10, how comfortable they would personally feel undergoing a medical operation performed by a robot. Around that single outcome, the researchers assembled three clusters of explanatory variables: sociodemographic characteristics including sex, age, education, income and political ideology; attitudes toward and familiarity with AI; and perceptions of AI regulation, including awareness of the European Union’s AI Act.

The headline result is sobering for anyone expecting enthusiasm. Overall comfort with robot-performed surgery was moderate to low, averaging roughly 4 on the 10-point scale, and the differences between groups were substantial. Men reported a mean comfort score of 4.83, compared with just 3.77 for women, a statistically significant gap. Even more counterintuitive is the age pattern: comfort rose steadily across the life course, from 3.67 among respondents aged 18 to 34 to 4.79 among those 65 and older, inverting the familiar stereotype of tech-wary seniors and digital-native optimists. Income and education also mattered, with the highest earners, those bringing in more than 6,000 euros per month, recording the highest mean comfort of any income group at 5.23, while people with no formal education scored lowest.

To disentangle these overlapping factors, the researchers built hierarchical linear regression models, entering variables in three theoretical blocks and measuring how much explanatory power each block added. Sociodemographics alone explained 7.1 percent of the variance in comfort. Adding attitudes toward AI pushed the total to 15.8 percent, the single largest jump in the analysis. The regulation block contributed a further, more modest increment, bringing the final model to 16.8 percent of explained variance. The statistics themselves tell a story: what people believe and feel about artificial intelligence matters more for their comfort with robotic surgery than who they are, and governance perceptions, while real, play only a supporting role.

Within the final model, the strongest predictor by a clear margin was the perceived benefits of AI, measured as a count of the domains in which respondents thought AI would do more good than harm, with a standardized coefficient of 0.244. Age followed at 0.207, confirming that older Spaniards were markedly more at ease with the surgical scenario. Positive feelings toward AI, self-reported knowledge, household income, and education all contributed smaller positive effects. On the negative side, agreeing that implementing stricter ethical standards and legal safeguards for AI is one of humanity’s most significant challenges was the strongest reducer of comfort at minus 0.094, followed by being female at minus 0.093 and holding more right-wing ideological positions at minus 0.062.

The gender gap deserves particular attention because it echoes a growing international literature. Previous studies have found that women use generative AI tools less frequently, in large part because they are more sensitive to the social and ethical risks these technologies pose, and research on robotic surgery has repeatedly shown men expressing more favorable attitudes and greater willingness to undergo robot-assisted procedures. The Spanish data are consistent with that pattern, although the authors are careful about interpretation: they did not estimate interaction or mediation models, so they cannot say whether women prioritize harms while men emphasize benefits. Differential risk perception, unequal technological exposure, and differing healthcare experiences all remain plausible explanations to be tested directly in future work.

The age finding is equally puzzling and deliberately hedged. Much research links older age to lower acceptance of digital technologies, and studies of AI adoption among older adults emphasize that the real driver is the combination of age with digital literacy rather than age itself. Yet in this surgical scenario, older respondents were the most comfortable group. The authors suggest several non-exclusive explanations: greater perceived healthcare need, stronger expectations of clinical benefit, cohort effects, or even the way the survey question was worded. What they reject is the leap to a general claim that older citizens embrace healthcare AI more broadly; the result is a context-specific association that requires replication before it can be generalized.

Perhaps the most politically consequential finding concerns regulation. Awareness of the EU AI Act, adopted in 2024 to impose safeguards on high-risk AI applications, and general agreement with AI regulation showed no independent positive association with comfort in the adjusted models. The regulatory block added only about one percentage point to explained variance. In raw means, people who had heard of the AI Act did report slightly higher comfort, 4.65 versus 4.02, and supporters of the law scored 4.88 versus 3.99, but these unadjusted differences may simply reflect confounding by education, income, ideology or AI knowledge. The authors conclude that the formal existence and public visibility of regulation cannot be assumed to translate automatically into comfort with a specific application, a caution that cuts directly against the common assumption that passing laws is enough to win public trust.

The study is explicit about its limits. The outcome is a single hypothetical item about robot surgery, not actual patient behavior, and the survey captured no direct measures of trust in technology, clinicians, hospitals or regulators, leaving trust as a theoretically important but untested mechanism. Most individual variation, more than 83 percent, remains unexplained, and factors such as health status, prior experience with robotic procedures, and knowledge of human oversight were absent from the questionnaire. Spain’s predominantly public healthcare system and its specific regulatory context also shape the findings. Still, the message for policymakers is pointed: deploying the technology, enacting regulations, and issuing public information campaigns are not sufficient conditions for acceptance. Making the role of professionals, the degree of human oversight, accountability arrangements and expected clinical benefits genuinely intelligible to different social groups, the authors argue, is what responsible implementation of healthcare AI must now deliver.

Subject of Research: Public comfort with robot-performed surgery in Spain and its social, political, and regulatory correlates

Article Title: Public receptiveness to healthcare AI in Spain: social, political, and regulatory correlates in a surgical scenario

Article References: Loureiro-Álvarez, I., Savostsikava, A., & Bouzas-Lorenzo, R. (2026). Public receptiveness to healthcare AI in Spain: social, political, and regulatory correlates in a surgical scenario. Frontiers in Political Science, 8, Article 1947858. https://doi.org/10.3389/fpos.2026.1947858

Image Credits: AI Generated

DOI: 10.3389/fpos.2026.1947858

Keywords: artificial intelligence, robotic surgery, healthcare AI, public opinion, Spain, EU AI Act, political ideology, gender gap, technology acceptance, digital divide, survey research, health policy

The perspective, written by Kellie Owens, Maggie Ramatowski, and Saul B. Blecker of New York University Grossman School of Medicine, draws on social science research and the authors’ own experiences deploying AI models in real healthcare settings. Their central claim is technically precise and socially explosive at the same time: implementation itself is a major driver of bias in healthcare AI. The ways AI systems are adopted, interpreted, and applied in practice—shaped by institutional norms, professional hierarchies, and patient characteristics—can reproduce or even amplify inequities that no dataset diversification could ever prevent.

The technical foundation of the argument rests on a distinction that fairness engineering has largely ignored. Most current approaches to algorithmic fairness draw on principles of distributive justice, asking whether a model allocates recommendations or resources equitably across socially salient groups such as race, gender, or age. A model might show similar sensitivity or positive predictive value across demographic groups—hallmark mathematical signals of fairness—and still introduce bias at the point of use. The reason is that these metrics presume model outputs directly drive decisions, when in reality clinicians serve as crucial intermediaries. Clinicians choose whether to consult a model at all, and each decision point introduces variation, and with variation comes the potential for bias.

Social scientists have long documented that algorithmic outputs are not inert facts but tools shaped by interpretation and context. Prior research on how clinicians act on algorithmic input shows that they may use or ignore recommendations based on their own judgments of the model’s value, and that healthcare workers and patients hold different expectations that shape how data is understood. AI outputs become embedded in complex feedback loops, altering individual decisions, broader workflows, and professional norms. The introduction of AI into clinical care is deeply social, woven into institutional routines, power dynamics, and historically rooted patterns of discrimination. Understanding these dynamics, the authors insist, requires looking beyond the algorithm itself.

Although the authors are unaware of studies directly examining bias in the implementation of AI-based algorithms in healthcare, emerging evidence from clinical decision support systems offers troubling clues. Studies indicate that the effectiveness of decision support tools can differ across gender and age, and some reports suggest providers may incorporate recommendations differently depending on patient characteristics. These patterns of uneven uptake may reflect familiar dynamics—workflow constraints, trust levels, or cognitive biases such as automation bias, in which clinicians defer to system outputs without adequate scrutiny. Clinicians often do not even know whether a decision support tool is AI-based.

Yet AI may introduce distinct challenges of its own. Because AI systems are often perceived as more objective or personalized than traditional decision support, they may heighten automation bias, making clinicians more likely to accept outputs at face value. Conversely, limited AI literacy or lack of transparency can make it difficult for clinicians to appropriately evaluate model outputs, producing overreliance in some cases and unwarranted skepticism in others. In the authors’ own research and experience, clinicians may use AI models differently depending on which patient is in front of them, mirroring existing power dynamics and social hierarchies. Clinicians may be more likely to accept AI recommendations at face value for marginalized patients, while subjecting outputs to greater scrutiny or repeated testing for more socially advantaged patients. Fairness, in other words, is entangled with dynamics of trust, authority, and power—not reducible to model accuracy alone.

This finding strikes at the heart of the most widely proposed safeguard in AI governance: the human-in-the-loop. The assumption behind this strategy is that clinicians, by exercising judgment, will act as a fail-safe against algorithmic error or bias. The authors suggest the opposite. Clinicians themselves are a major site where inequities emerge, and placing primary responsibility for fairness on individual clinicians risks reinforcing rather than mitigating structural inequities. Humans, they write, are often the very conduit through which inequities enter the system. Institutions that assume human oversight guarantees fairness are making a dangerous assumption—one that recent literature has begun to question, with some proposals favoring supervisory oversight over more autonomous systems instead of active clinician-AI collaboration.

To move from descriptive concern to testable science, the authors lay out a concrete research agenda. One approach is to examine whether and how clinicians differentially use, ignore, or override AI recommendations based on patient characteristics such as race, gender, or socioeconomic status, using audit log data linked to clinical and demographic information. A second line of inquiry should focus on conditions of use: whether time pressure, workload, or alert fatigue increases reliance on AI, and whether these effects vary across patient groups. Qualitative and ethnographic approaches—observational studies of clinical workflows and in-depth interviews with clinicians and patients—can surface how AI outputs are made meaningful in context and how competing definitions of fairness are reconciled in practice. Finally, linking patterns of AI use to downstream clinical decisions and outcomes is essential to determine whether these dynamics translate into inequities in care.

On the governance side, the authors call for a shift from human-in-the-loop to system-in-the-loop oversight, placing responsibility across healthcare organizations, regulators, and technology vendors. That framework includes continuous monitoring for disparities in AI use and outcomes across patient populations, with dashboards that track differential exposure to AI recommendations, override rates, and downstream outcomes by relevant subgroups. Institutional policies should standardize when AI recommendations must be considered or documented—for example, requiring clinicians to provide brief justification when overriding certain recommendations, or generating periodic audit reports for review by governance committees. Workflows should account for clinician workload and decision fatigue, recognizing that alert fatigue or lack of time may systematically disadvantage some groups of patients more than others. Vendors, too, should bear greater responsibility for post-deployment monitoring, transparency, and collaboration with health systems, including providing tools for subgroup performance auditing and tracking clinician interaction patterns.

The authors are careful to note that differences in how AI tools are used across patient groups are not necessarily evidence of unfair implementation. A high override rate for a particular group could indicate either appropriate clinical correction of model outputs or inequitable disregard of recommendations—disentangling the two is precisely what systematic tracking is for. But the broader message is unambiguous. Fairness is not only designed into models; it is negotiated and enacted in practice. By acknowledging that clinicians are not neutral backstops but active participants whose judgments are socially patterned, healthcare systems can design governance strategies that take human behavior seriously. The future of equitable AI in medicine, this perspective argues, depends less on perfecting the algorithm and more on governing the messy, human system around it.

Subject of Research: Health equity and AI governance in clinical decision support

Article Title: Promoting Fairness in AI Implementation

Article References: Owens, K., Ramatowski, M., & Blecker, S. B. (2026). Promoting Fairness in AI Implementation. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10767-y

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10767-y

Keywords: artificial intelligence, healthcare AI, algorithmic bias, clinical decision support, health equity, human-in-the-loop, AI governance, medical ethics, Promoting, Fairness, Implementation, scientific research

Researchers at the University of Pittsburgh School of Medicine recruited 44 internal medicine teaching faculty from a single large academic medical center and asked them to review four clinical vignettes, each describing a patient scenario with a management decision to be made. For every case, the participants read a piece of electronic consultation advice, or e-consultation, generated by OpenEvidence, a medically specialized generative AI system that has rapidly become one of the most widely used clinical AI platforms among physicians. Before and after reading the advice, the physicians answered multiple-choice questions about how they would manage the patient, allowing the investigators to measure whether the AI’s recommendations actually changed their decisions.

The study’s central twist was a randomization scheme. Half of the participants were told the advice had been written by a specialist attending physician, while the other half were told it came from a medically specialized artificial intelligence system. In reality, all of the advice was AI-generated. The design allowed the researchers to isolate whether the label alone, the perceived source of the advice, influenced how physicians judged its quality or whether they adopted its recommendations.

The results were striking in their uniformity. Across six domains of perceived quality, completeness, actionability, clarity, appropriateness, trustworthiness, and use of evidence-based practice, the physicians gave the advice high marks, with overall mean ratings ranging from 4.2 to 4.7 on a 5-point scale. Critically, there were no statistically significant differences between the group that believed the advice came from a human specialist and the group that knew it came from an AI system. The label, in other words, did not matter.

The adoption data were even more dramatic. Before reading the e-consultation advice, only 37.5 percent of participants chose the management option that the AI would later recommend. After reading it, that figure jumped to 81.8 percent, an odds ratio of 8.43 with a 95 percent confidence interval of 5.00 to 14.28 and a p-value below 0.001. Whether the physicians thought they were reading the words of a human colleague or a machine made no measurable difference in this shift, with an odds ratio of 1.18 for the labeling effect and a confidence interval spanning 0.51 to 2.75.

These findings arrive at a moment when generative AI tools are being integrated into clinical workflows at unprecedented speed. OpenEvidence, the platform used in the study, has been described by its own developers as the fastest-growing application for physicians in history, following a funding round that valued the company at 3.5 billion dollars. Prior research has shown that large language models can perform at expert level on complex diagnostic challenges, and earlier studies have documented that clinicians’ diagnostic reasoning can be swayed by AI input, sometimes for better and sometimes for worse. What this new study adds is direct evidence that experienced teaching faculty, the physicians responsible for training the next generation, rate AI-generated consultation advice as highly as they would rate human specialist advice, and change their management decisions accordingly.

The context of e-consultation matters here. Electronic consultations, in which a primary care clinician submits a question to a specialist asynchronously rather than referring the patient for an in-person visit, have expanded rapidly as a means of improving access to specialty expertise. Systematic reviews have documented their benefits for connecting primary care to hospital-level expertise, but studies have also identified suboptimal e-consult requests and variable adherence to specialist recommendations. The Pittsburgh study suggests that when the consultant is an algorithm rather than a human specialist, physicians may be just as receptive, and just as likely to act on what they read.

That receptiveness cuts both ways. On one hand, if AI-generated advice is accurate, well-referenced, and genuinely useful, high adoption rates could accelerate the dissemination of best practices and reduce variation in care. Prior work has shown that management changes following multidisciplinary team discussions are associated with improved survival outcomes for cancer patients, and that second opinions in general internal medicine frequently alter diagnoses and management plans. If an AI system can approximate the value of a specialist consultation, the implications for access and efficiency are enormous, particularly in underserved areas where specialist availability is limited.

On the other hand, the study’s authors and the broader literature caution that susceptibility to AI recommendations is not inherently benign. Research on clinical decision support has shown that clinicians can be overly compliant with algorithmic advice, a phenomenon sometimes called automation bias, and recent work has demonstrated that the correctness of AI recommendations directly affects diagnostic accuracy in clinical decision-making. If physicians adopt AI-generated advice at rates approaching 82 percent regardless of its source, the quality assurance burden shifts from the individual clinician to the system itself. The study did not evaluate whether the AI’s recommendations were objectively correct for each vignette, only whether physicians found them persuasive and acted on them.

The researchers also note that their participants were teaching faculty at a single academic medical center, a group that may be more familiar with AI tools than the average clinician, and that the vignettes were hypothetical rather than live patient cases. Whether the same patterns hold in real clinical settings, with real patients and real time pressures, remains an open question. The authors call for future studies to explore what factors influence the adoption of AI-generated recommendations and how curricula for faculty and trainees can shape consultation utilization. As generative AI becomes embedded in the daily workflow of medicine, understanding not just what these systems say but how physicians respond to them may prove as important as the underlying technology itself.

Subject of Research: Physician perceptions and adoption of AI-generated e-consultation advice in clinical decision-making

Article Title: Physician Ratings and Adoption of AI-Generated e-Consultation Advice: A Randomized Clinical Vignette Study

Article References: Desjardins, G., Jain, V., Simonson, M. G., & McQuade, C. N. (2026). Physician Ratings and Adoption of AI-Generated e-Consultation Advice: A Randomized Clinical Vignette Study. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10777-w

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10777-w

Keywords: generative artificial intelligence, e-consultation, clinical decision-making, internal medicine, OpenEvidence, randomized vignette study, physician perceptions, medical education, automation bias, clinical reasoning, Journal of General Internal Medicine, healthcare AI

Digital twins, virtual replicas of physical systems that update in real time as new data arrive, have transformed manufacturing and are steadily migrating into healthcare. In cardiology, diabetes management and pathology, researchers are building patient-specific models that can simulate how a disease might evolve under different treatment scenarios. But a clinical digital twin is only as good as its predictive core, and that core faces a dilemma familiar to anyone working in medical artificial intelligence: the most accurate models are often the least explainable, and the most explainable models are often the least accurate.

The new framework, called MiG-FRBS, short for Michigan-style Genetic Fuzzy Rule-Based System, attempts to resolve that tension by design. Fuzzy logic, a mathematical approach that handles uncertainty through degrees of truth rather than binary yes-or-no categories, produces rules that read almost like clinical reasoning. A rule might state that if a patient’s pyramidal subscore is moderately elevated and their cerebellar function is slightly impaired, then their overall disability is likely to increase. Genetic algorithms, optimization techniques inspired by natural selection, then evolve and refine these rules automatically, breeding generations of candidate rules and keeping only those that best fit the data.

The Michigan-style architecture, named after the approach pioneered at the University of Michigan in the 1970s, encodes each fuzzy rule as an individual organism in the evolving population. This contrasts with Pittsburgh-style systems, where entire rule sets compete as units. The Michigan design allows the algorithm to discover a diverse collection of complementary rules, each covering a different region of the patient data, which naturally produces compact and human-readable rule bases rather than sprawling libraries of overlapping logic.

One of the study’s key technical innovations is its treatment of time. Multiple sclerosis patients typically visit clinics at irregular intervals, sometimes months apart, and their records capture snapshots rather than continuous trajectories. To bridge these gaps, the researchers applied spline-based interpolation, a mathematical technique that fits smooth polynomial curves through known data points, generating synthetic time-series data that allows the model to forecast continuously rather than only at visit dates. The framework accepts both raw measurements and differenced inputs, the latter capturing changes between consecutive time points, which helps the system detect trends and rates of deterioration rather than absolute levels.

Another structural choice sets the system apart from conventional forecasting models. Instead of predicting a single aggregate disability score, MiG-FRBS employs a Multiple Input Multiple Output, or MIMO, architecture that predicts several functional subscores of the Expanded Disability Status Scale simultaneously. The EDSS, the standard clinical measure of MS disability, decomposes into subscores covering distinct neurological systems, including pyramidal, cerebellar, brainstem, sensory, bowel and bladder, visual, cerebral and ambulation functions. By forecasting these components in parallel, the model builds a richer virtual representation of a patient’s overall condition, capturing the fact that disability in MS does not progress uniformly across all systems.

The choice of Gaussian membership functions, smooth bell-shaped curves that define how strongly a given value belongs to a fuzzy category, reflects both mathematical and practical considerations. Gaussian functions are continuous, symmetric and differentiable everywhere, which avoids the abrupt boundaries that plague triangular or trapezoidal membership functions and produces more stable inference when inputs shift slightly. This smoothness matters in a clinical setting, where a small change in a measured value should not cause the model’s output to jump discontinuously.

When evaluated on real patient data from King Fahd Specialist Hospital, the framework delivered promising results while preserving interpretability. Predictions of mental subscores achieved accuracies above 90 percent, while brainstem and bowel subscores exceeded 80 percent accuracy. Those figures are notable not despite the model’s transparency but arguably because of its design philosophy. Rather than fitting thousands of opaque parameters, the system distills its knowledge into a small set of succinct rules that clinicians can inspect, question and trust. The authors argue that this positions MiG-FRBS as the virtual modelling layer of a digital twin, an engine that forecasts disease progression in a form that supports, rather than replaces, clinical judgment.

The work arrives amid a wave of machine learning efforts to predict MS progression. Recent studies have applied deep learning architectures, including LSTM networks, to forecast five-year EDSS scores, and neural networks trained on routinely collected healthcare data to estimate disability. Explainable AI methods have been used to identify which baseline MRI features predict disease trajectory. Yet most of these approaches treat interpretability as an afterthought, applying post-hoc explanation tools such as SHAP values to models that were never designed to be understood. The genetic fuzzy approach inverts that logic, building explainability into the model’s very structure.

Significant hurdles remain before such a system reaches the clinic. The training data came from a single hospital and are not publicly available, raising questions about generalizability across populations and healthcare settings. Sparse clinical records, even with interpolation, may not capture the full complexity of disease dynamics that continuous monitoring could reveal. And any digital twin deployed in practice would need rigorous prospective validation, demonstrating that its forecasts improve outcomes rather than merely match retrospective data. Still, the study offers a concrete template for how interpretable, evolutionarily optimized models could anchor the next generation of personalized neurological care, where a patient’s digital counterpart evolves alongside them, rule by transparent rule.

Subject of Research: A genetic fuzzy rule-based system for predicting multiple sclerosis disability progression as the predictive core of a clinical digital twin

Article Title: A Michigan style genetic fuzzy system framework for multiple sclerosis: towards a digital twin application

Article References: Faisal, M., Ahmed, M., Khan, S., & Bunyan, R. F. (2026). A Michigan style genetic fuzzy system framework for multiple sclerosis: towards a digital twin application. Applied Intelligence, 56(16), Article 497. https://doi.org/10.1007/s10489-026-07545-y

Image Credits: AI Generated

DOI: 10.1007/s10489-026-07545-y

Keywords: multiple sclerosis, digital twin, genetic fuzzy systems, fuzzy logic, genetic algorithms, EDSS, interpretable machine learning, time series forecasting, clinical decision support, spline interpolation, predictive modeling, healthcare AI

The research team built their framework around two public datasets. The first was a global fertility rate time series spanning 1960 to 2020, drawn from Kaggle, which captures decades of demographic change across countries. The second was an electronic health record-derived male fertility dataset containing 100 participants and 10 features, originally sourced from the UCI Machine Learning Repository. Each participant’s sperm concentration had been assessed against World Health Organization 2010 standards, and the features ranged from age and season of assessment to childhood diseases, surgical history, alcohol consumption frequency, smoking habits, and daily sitting duration. The diagnosis column, classifying each man as having normal or altered fertility, served as the prediction target.

Before any modeling began, the researchers put both datasets through a rigorous preprocessing pipeline. Missing years were removed from countries with incomplete temporal sequences in the fertility rate data, and values were normalized using Min-Max scaling before being converted into fixed-length sliding windows of ten years. For the male fertility dataset, categorical variables such as season and alcohol frequency were one-hot encoded, binary variables were label encoded, and numerical features like age and sitting hours were standardized. The team also checked for multicollinearity using Pearson’s correlation, retaining only features below a threshold of 0.85, and addressed class imbalance through random undersampling to preserve generalizability.

With the data prepared, the researchers deployed an unusually broad arsenal of Long Short-Term Memory (LSTM) architectures. LSTMs are a type of recurrent neural network designed to model sequential data while sidestepping the vanishing gradient problem through memory cells and gating mechanisms. The team tested unilateral LSTMs, which process sequences in a single forward direction; bidirectional LSTMs, which read data from both past and future contexts; hierarchical and attention-based LSTMs, which layer recurrent processing and dynamically weight the most informative time steps; convolutional LSTMs, which replace fully connected operations with convolutions inside the gating mechanism; LSTM autoencoders, which compress and reconstruct sequences; grid LSTMs, which extend recurrence across multiple dimensions; and cross-modal and associative LSTMs, which integrate information from multiple data types. Each variant was configured with 64 hidden units, tanh activation, sigmoid gates, a dropout rate of 0.2, the Adam optimizer, a learning rate of 0.001, and a batch size of 32, trained for 20 epochs with early stopping.

The centerpiece of the study, however, was a novel Quantum LSTM that embeds a Variational Quantum Circuit (VQC) directly within the LSTM’s input gating mechanism rather than using it as a postprocessing feature extractor, as most prior hybrid quantum-classical models have done. The quantum component used eight qubits with angle encoding via RX and RY rotations, two variational layers with CNOT entanglement gates, and a circuit depth of 18 gates per forward pass, yielding 64 trainable quantum parameters. The circuit replaced the input-to-hidden weight matrix in the LSTM’s input gate only, leaving the forget, output, and cell gates entirely classical. This architectural choice allows quantum superposition and entanglement to directly influence temporal memory updates, a distinction the authors argue sets their approach apart from earlier designs that treat quantum circuits as bolt-on feature enhancers.

To establish a fair baseline, the team also ran four conventional machine learning algorithms on both datasets: logistic regression, random forest, support vector machine, and XGBoost. XGBoost emerged as the strongest classical baseline, achieving 89.4 percent accuracy on the fertility rate data and 89.7 percent on the male fertility data, with random forest close behind at 88.3 and 89.2 percent respectively. These results confirmed that ensemble-based methods remain formidable competitors on small, structured datasets, but they also underscored the value of LSTM architectures for capturing sequential and temporal patterns that tree-based models cannot easily represent.

Among the classical LSTM variants, the unilateral LSTM proved the most consistent performer, reaching 91.2 percent accuracy on the fertility rate dataset in 79 seconds and 92.1 percent on the male fertility dataset in 82 seconds. The Quantum LSTM outperformed all classical models on both datasets, achieving 92.6 percent accuracy on the fertility rate data with a training time of 74 seconds and 93.8 percent on the male fertility data in 79 seconds. The absolute improvement over the best classical baseline was modest, roughly one to two percentage points, but the team validated it through three independent strategies: fivefold cross-validation to reduce bias, ten repeated random train-test splits to measure variance and stability, and 1,000 iterations of bootstrap resampling to quantify uncertainty through confidence intervals.

Statistical testing confirmed that the Quantum LSTM’s advantage was real rather than an artifact of sampling noise. The Friedman non-parametric test, applied across repeated validation runs, revealed significant differences among the LSTM architectures on both datasets, with P-values of 0.0009 for the fertility rate data and 0.0012 for the male fertility data. Pairwise Wilcoxon signed-rank tests comparing the Quantum LSTM against the unilateral LSTM across fivefold cross-validation yielded P-values of 0.031 and 0.024, both below the conventional 0.05 threshold, with small to moderate effect sizes (Cohen’s d of 0.42 and 0.48). The Quantum LSTM also exhibited narrower bootstrap confidence intervals and lower standard deviations than its classical counterpart, suggesting greater stability under repeated resampling even with limited data.

To make the model’s decisions transparent, the researchers applied SHAP (SHapley Additive exPlanations), an interpretability framework rooted in cooperative game theory that assigns each feature an importance value based on its marginal contribution to predictions. On the male fertility dataset, daily sitting duration emerged as the single most influential predictor, with a mean absolute SHAP value of approximately 0.22, followed closely by age at roughly 0.18. Season of assessment and frequency of alcohol consumption ranked third and fourth with importance scores of about 0.13 and 0.12 respectively. Clinical history variables, including smoking habits, childhood diseases, accidents or serious trauma, high fevers in the last year, and surgical intervention, contributed comparatively less, with SHAP values ranging from approximately 0.07 to 0.08. On the fertility rate dataset, SHAP analysis revealed that the most recent years, particularly 2019, carried the greatest predictive weight, while observations from earlier decades such as 1985 and 2001 contributed far less, indicating that the model relies on both short-term and long-term temporal dependencies.

The authors are careful to frame their findings as hypothesis-generating rather than clinically conclusive. The male fertility dataset contained only 100 participants from a single source, the quantum circuit was executed on a simulator rather than real quantum hardware, and all observed associations between fertility outcomes and lifestyle or clinical variables are correlational, not causal. The study also lacked genetic, hormonal, imaging, and longitudinal data, and the models are not intended for direct clinical deployment. Nevertheless, the work establishes a reproducible benchmarking framework that combines classical LSTM variants, a quantum-enhanced LSTM, and SHAP-based explainability for exploratory male infertility risk stratification. The researchers call for future validation on larger, multi-center electronic health record cohorts and on real quantum hardware, where gate noise, decoherence, and qubit connectivity constraints will test whether the modest gains observed in simulation translate into meaningful clinical advantage.

Subject of Research: A hybrid quantum-classical deep learning framework for interpretable male infertility risk prediction using electronic health record data

Article Title: A data-driven and interpretable hybrid quantum-classical model for male infertility risk assessment

Article References: Sarath, T., & Brindha, K. (2026). A data-driven and interpretable hybrid quantum-classical model for male infertility risk assessment. Frontiers in Medical Technology, 8, Article 1853728. https://doi.org/10.3389/fmedt.2026.1853728

Image Credits: AI Generated

DOI: 10.3389/fmedt.2026.1853728

Keywords: male infertility, quantum machine learning, LSTM, variational quantum circuit, electronic health records, SHAP, deep learning, fertility prediction, quantum computing, risk assessment, healthcare AI, reproductive medicine

The review’s central finding is stark: the performance gap between English and Bangla medical AI is not incidental but structural. English systems benefit from massive domain-specific pretraining corpora, standardized benchmarks such as MedQA and MedMCQA, and well-established evaluation practices. Bangla systems, by contrast, grapple with tiny datasets, heavy reliance on machine-translated English text, and no shared benchmarks at all. The authors describe this as an asymmetry in the maturity of the entire research ecosystem, not merely a difference in model capability.

To organize the field, the researchers built a taxonomy of eight methodological paradigms, classified by the mechanism that produces answers at inference time. These range from rule-based systems using hand-crafted lexicons, through supervised neural models and transformer fine-tuning, to prompt-based inference, parameter-efficient adaptation, retrieval-augmented generation, multi-task learning, and multimodal question answering. Where a study combined approaches, the authors assigned it to the paradigm its own evaluation credited with the principal performance gain.

The trajectory of Bangla medical NLP mirrors the broader evolution of the field. Early systems were rule-based and database-driven. One 2022 effort, XBLQPS, combined tokenization, root extraction, part-of-speech tagging, and a simplified LESK algorithm for word sense disambiguation to map Bangla health queries onto structured database lookups, achieving about 70 percent accuracy. Later work shifted to statistical and classical machine learning: researchers built datasets such as BnMedText and BnMedQA, applied TF-IDF and word embedding features, and trained classifiers including support vector machines and random forests, alongside a hybrid CNN-BiLSTM model called MeQANet.

Transformer architectures then raised the ceiling on contextual understanding. A team curating the BanglaCHQ-Summ dataset of 2,350 conversational health query pairs fine-tuned BanglaT5, mT5, and mBART for medical summarization, with BanglaT5 reaching a ROUGE-L score of 48.35 percent and a BERTScore of 89.91 percent. Notably, language-specific models consistently outperformed multilingual counterparts, a pattern repeated in named entity recognition, where BanglishBERT achieved the highest F1 on informal Bangla clinical text while zero-shot GPT-3.5 managed only 15.51 percent on the Bangla-HealthNER dataset.

Prompt-based methods have produced some of the most striking results. On a 659-sample Bangla medical dataset for specialty recommendation, zero-shot GPT-4-Turbo scored an F1 of just 38.2 percent, but mixed prompting strategies lifted the same model to 86.1 percent. The catch, the review notes, is that such gains depended on manual prompt engineering, and the dataset itself suffered from class imbalance and gender and organ biases. Parameter-efficient fine-tuning has also emerged as a practical pathway: applying LoRA to a Gemma-2B model demonstrated effective domain adaptation on a small 300-pair Bangla medical QA dataset, though the study was qualitative only and lacked baseline comparisons.

On the English side, the review documents far more sophisticated machinery. Multi-task learning with ClinicalBERT improved answer-extraction F1 by 2.2 percent and classification accuracy by 6.2 percent over single-task training on the emrQA dataset. Retrieval-augmented generation has become the dominant strategy for compensating for LLM knowledge gaps: the MKRAG framework combined two-stage retrieval with knowledge injection through in-context learning, improving Vicuna-7B accuracy by 4.08 percent without any fine-tuning, while the RAG2 system, which generates chain-of-thought rationales to guide retrieval and filters evidence with a perplexity-guided model, improved accuracy by up to 6.1 percent across MedQA, MedMCQA, and MMLU-Med. Crucially, the review emphasizes that retrieval quality matters more than quantity, since irrelevant context actively degrades accuracy.

Yet even English-language success comes with caveats that carry sobering implications for any language. One 2026 evaluation found ChatGPT-4 answered only 1 of 14 breast cancer exercise counseling questions reasonably accurately against clinical guidelines. Other work showed weak correlation between open-ended and closed-ended benchmark performance, and that selecting the lowest-uncertainty responses improved accuracy without architectural changes, suggesting that knowing when not to answer is as clinically valuable as answering correctly. Strong benchmark scores, the authors conclude, do not automatically translate into trustworthy responses in nuanced clinical contexts.

The structural constraints on Bangla medical QA are formidable. Existing corpora are tiny, such as the roughly 4,500 QA pairs in BnMedQA or the 659 patient-symptom pairs used in prompting studies, and many rely on machine translation from English, introducing semantic drift and cultural misalignment. Classifiers trained on translated data collapse on semantically broad categories like general medicine while performing reliably on specialties with distinctive vocabulary such as gynecology or ENT. No Bangla symptom-based diagnostic QA dataset exists, none include clinician-validated ground truth, and datasets remain almost entirely text-only despite the multimodal reality of clinical medicine. Bangla’s rich morphology, dialectal variation, and code-switching with English further strain models trained primarily on English corpora.

The review closes with a structured roadmap. The authors call for building the first clinician-validated Bangla symptom-based diagnostic QA dataset, developing expert-annotated corpora that capture dialectal variation and code-mixed text, pursuing domain-specific pretraining on native Bangla medical text with parameter-efficient methods such as LoRA and QLoRA, rebuilding retrieval pipelines around native-language knowledge bases, and establishing standardized benchmarks derived from sources excluded from model pretraining. Bias auditing and lightweight deployment strategies, they argue, should be prerequisites for any clinical deployment. The message is clear: the goal is not to replicate English models but to build the language-specific resources and evaluation infrastructure that make reliable, linguistically inclusive medical AI possible for the hundreds of millions who ask their health questions in Bangla.

Subject of Research: Large language model approaches to medical question answering in Bangla and cross-lingual comparison with English systems

Article Title: A mini-review of medical question answering for Bangla: the methodological landscape and cross-lingual perspectives

Article References: Mahmud, J. S., Ratri, K. A., Hosen, M. H., Morol, M. K., Hui, L. T., Nandi, D., Jubair, A. A., & Rahman, M. (2026). A mini-review of medical question answering for Bangla: the methodological landscape and cross-lingual perspectives. Frontiers in Digital Health, 8, Article 1856734. https://doi.org/10.3389/fdgth.2026.1856734

Image Credits: AI Generated

DOI: 10.3389/fdgth.2026.1856734

Keywords: Bangla NLP, medical question answering, large language models, retrieval-augmented generation, low-resource languages, healthcare AI, transformer fine-tuning, parameter-efficient fine-tuning, LoRA, prompt engineering, benchmarking, digital health

The core problem the study addresses is what the author calls rare-disease spillover. When an unlearning procedure is applied to a medical image classifier, the update does not merely erase the targeted records. Gradient-based deletion methods reshape the model’s internal decision boundaries, and those boundaries are often far more fragile for minority classes — the rare diagnoses that appear in only a handful of training images — than for common ones. A model can lose a substantial fraction of its rare-class accuracy while its aggregate F1 score, the metric most dashboards report, barely moves. The study formalizes this discrepancy with a statistic called the Rare-Disease Spillover Index, or RDSI, which measures the differential change in utility experienced by rare classes relative to the model’s overall performance after an unlearning update. Crucially, the author frames the RDSI as a reporting convention rather than an independent source of information, a deliberate design choice meant to prevent the statistic from being treated as a standalone certification of safety.

The experimental evidence is stark. Working with HAM10000, a widely used openly available dataset of dermatoscopic images of pigmented skin lesions, the study used a fixed lesion-disjoint partition — meaning images from the same patient’s lesion never straddle the training and evaluation sets, a detail that matters enormously in dermatology where multiple images of one lesion can otherwise inflate apparent performance. On this partition, an aggressive gradient-ascent unlearning method known as NegGrad produced an F1-based RDSI of 0.373, with a paired lesion-bootstrap confidence interval of [0.291, 0.449]. In plain terms, the rare classes suffered a large and statistically robust drop in utility that would be invisible in aggregate metrics. By contrast, ordinary retraining on the retained data alone — the naive baseline of simply rebuilding the model without the deleted records — yielded an RDSI of just 0.052, with an interval spanning [-0.014, 0.114] that includes zero. The gap between these two numbers carries the study’s central message: how successfully a model forgets and how much collateral damage it inflicts are two separate questions that demand separate assessment.

This distinction has direct regulatory weight. Privacy frameworks such as the GDPR and emerging AI governance rules treat data deletion as a compliance obligation, and unlearning methods are attractive precisely because retraining a large clinical model from scratch for every deletion request is expensive and slow. But the audit shows that a fast unlearning update can satisfy the letter of a deletion request while quietly degrading the model’s clinical value for the patients who need it most. Rare diagnoses — unusual skin cancers, uncommon radiographic findings — are exactly the cases where clinical AI assistance is most valuable and where the training data is thinnest. A deletion procedure that erodes rare-class performance is therefore not a neutral maintenance operation; it is a potential patient-safety event that no current compliance checklist would catch.

The study does not stop at diagnosis. It also evaluates a mitigation strategy that combines two ideas: rare replay, in which a small, carefully chosen set of retained rare-class examples is revisited during the unlearning update to anchor the model’s rare-class behavior, and prototype anchoring, a technique borrowed from few-shot learning research in which class prototypes — averaged feature representations — serve as reference points that stabilize the encoder’s representation of rare categories. The illustrated replay-plus-anchor update achieved a test macro-F1 of 0.675 with a standard deviation of 0.020 across seeds, and a rare macro-F1 of 0.624 with a standard deviation of 0.038. For comparison, fresh retain-only retraining with the same rare-class-weighted loss function reached only a rare macro-F1 of 0.460 with a standard deviation of 0.029. The mitigation update also achieved a forget-set accuracy of 0.975 with a standard deviation of 0.014, versus 0.750 with a standard deviation of 0.020 for matched retraining — a number that, counterintuitively, signals residual predictive behavior on the forgotten images rather than successful deletion.

That last point deserves unpacking, because it reveals a subtle trap in unlearning evaluation. High accuracy on a forget set sounds like good news if you are measuring utility, but in the unlearning context it is a red flag: a model that still classifies deleted images accurately has not truly forgotten them. The study complements its utility comparisons with uniform probability distances, confidence diagnostics, and a retain-forget membership inference analysis — an adversarial test that asks whether an attacker can distinguish images the model trained on from images it did not. Successful unlearning should collapse that separability, making deleted records indistinguishable from never-seen ones. By pairing utility metrics with deletion-fidelity metrics, the audit framework forces both questions to be answered simultaneously, exposing methods that look safe on one axis while failing on the other.

Perhaps the most sobering result concerns the limits of the mitigation itself. In paired centroid-source controls, a retain-only encoder achieved a rare macro-F1 of 0.592 with a standard deviation of 0.033, compared with 0.608 with a standard deviation of 0.040 for the full-data encoder and 0.572 with a standard deviation of 0.022 for replay alone. In other words, simply matching the rare replay data does not reproduce the operating point achieved by the full mitigation pipeline, and swapping the anchor reference produced only a modest, uncertain incremental gain in utility. The author is candid about this: the mitigation is illustrative, not a finished prescription. The deeper contribution is the audit structure itself — raw class utilities, paired uncertainty quantification through lesion-level bootstrapping, and explicit retraining controls that let practitioners distinguish genuine rare-class preservation from artifacts of the evaluation setup.

The study also looked beyond dermatology, testing external chest-radiograph effects using openly available data from ChestX-ray14 and a credentialed subset drawn from MIMIC-CXR-JPG. There, the spillover effects were modest and heterogeneous, suggesting that the severity of rare-disease collateral damage depends on the dataset, the class structure, and the unlearning method. That heterogeneity is itself an argument for the audit: there is no universal safety margin that a hospital can assume when a model update deletes data. Each deletion event, on each deployed model, needs its own paired assessment of what was lost and whether the loss falls disproportionately on rare conditions.

What makes the work unusually verifiable is its commitment to reproducibility. The full pipeline — partitioning, training, unlearning, mitigation, auditing, and every reported calculation — is archived on Zenodo under an MIT license, complete with fixed split manifests, per-seed results, bootstrap distributions, and compact per-image predictions. The reported numbers can be recomputed without images, GPUs, or model checkpoints, and the credentialed chest-radiograph components are handled through identifiers and reconstruction scripts rather than redistributed data. In a field where unlearning claims are often difficult to check, this level of transparency sets a practical standard.

The broader implication is that healthcare AI needs a maintenance discipline analogous to pharmacovigilance. Models are not static artifacts; they are edited throughout their deployment lives as privacy requests arrive, datasets are corrected, and regulations evolve. The study’s framework treats each such edit as a potential safety event requiring a structured audit: measure raw per-class utilities before and after, quantify uncertainty at the level of correlated patient clusters, run explicit retraining controls, test deletion fidelity against membership inference, and report rare-class spillover alongside aggregate performance. As medical AI systems move from research demos into clinical infrastructure, the question is no longer only whether a model can forget on command, but whether the rest of the model — and the rare patients it serves — survives the forgetting intact. This audit provides the first systematic vocabulary for asking that question, and a reproducible toolkit for answering it.

Subject of Research: Machine unlearning safety in healthcare AI, focusing on rare-disease performance degradation and mitigation

Article Title: Rare-disease spillover after medical AI unlearning: a safety audit and mitigation framework for healthcare model maintenance

Article References: Kinalioglu, I. H. (2026). Rare-disease spillover after medical AI unlearning: a safety audit and mitigation framework for healthcare model maintenance. International Journal of Data Science and Analytics, 22(1), Article 342. https://doi.org/10.1007/s41060-026-01329-w

Image Credits: AI Generated

DOI: 10.1007/s41060-026-01329-w

Keywords: machine unlearning, healthcare AI, rare diseases, dermoscopy, HAM10000, membership inference, model maintenance, data deletion, medical imaging, safety audit, class imbalance, deep learning

The problem the researchers set out to solve is subtle but consequential. When a language model answers a medical question, it may produce text that looks plausible and even scores well on automated tests, yet quietly drops a critical detail, a medication name, a comorbidity, a laboratory value, that changes the clinical meaning of the answer. Traditional evaluation metrics, most of them borrowed from general-purpose natural language processing, compare a generated response against a reference answer using token overlap or the similarity of embedding vectors. Those approaches can penalize a correct paraphrase and reward a fluent but clinically hollow response. Worse, many of them require a gold-standard reference answer or laborious manual annotation, which makes them expensive to apply at scale and impractical for the fast-moving cycle of model development that defines modern artificial intelligence.

EntQA takes a different philosophical stance: instead of asking how similar two texts are, it asks which clinically relevant biomedical concepts from the patient background and the question are preserved in the model’s answer. The metric is reference-free, meaning it does not need a pre-existing correct answer to compare against. It extracts entities from the inputs, the patient-specific context and the diagnostic question, and measures how well the generated response retains them. In doing so, it aims to capture two things that benchmark accuracy alone cannot: whether the model’s reasoning preserves patient-specific context, and whether it stays true to the diagnostic intent embedded in the question. Because it relies on entity retention rather than human raters or reference texts, it can be computed automatically across thousands of responses, making it scalable in a way that expert evaluation never will be.

The technical evaluation behind the metric was unusually broad. The authors tested EntQA across five established medical question-answering benchmarks and seven models from the Qwen 2.5 Instruct family, spanning a dramatic range of scale from 0.5 billion to 72 billion parameters. This design allowed them to ask two distinct questions. First, does the metric track actual answer quality, as measured by conventional accuracy? Second, does it track model capability as models grow larger, which is a proxy for the general expectation that bigger models reason better? A useful evaluation metric should correlate positively with both; a misleading one might reward verbosity or fluency regardless of correctness.

The results were striking. Across the benchmarks and model sizes, EntQA showed consistently positive associations with both accuracy and scaling. Group-level correlations with accuracy reached a Spearman rank correlation coefficient of 0.9286, an exceptionally strong relationship that suggests the metric is capturing something fundamental about answer quality rather than incidental stylistic features. Correlations with model scale reached 0.252, a more modest but still positive association, indicating that the metric broadly rises with model capability even if scale alone does not fully determine entity retention. In other words, larger models do tend to hold on to more clinically relevant information, but the metric also discriminates among models of similar size, which is exactly where evaluation is hardest.

Perhaps more revealing than EntQA’s own performance was the behavior of the conventional metrics it was compared against. Overlap-based measures and embedding-based similarity scores frequently exhibited weak or even negative correlations with accuracy across the same experiments. A negative correlation is the most damaging possible outcome for an evaluation metric: it means that in some settings, the metric would systematically prefer worse models over better ones. The authors’ findings suggest that the field’s reliance on these inherited metrics is not merely imprecise but potentially actively misleading when applied to clinical question answering, where the relationship between textual similarity and clinical correctness breaks down in ways it may not in general-domain tasks.

The interpretability of EntQA is one of its most practical advantages. Because the metric is built around named biomedical concepts, a failing score can be traced to specific entities that a model dropped or distorted. An evaluation team can see not just that a model scored poorly, but what it lost, whether it omitted a patient’s hypertension history, ignored a drug interaction, or drifted away from the question’s diagnostic focus. This kind of granular, entity-level feedback is far more actionable for developers than a single aggregate accuracy number, and it aligns naturally with how clinicians audit each other’s reasoning, by checking whether the salient facts of a case were carried through to the conclusion.

The implications extend beyond benchmarking. As healthcare systems begin deploying language models in real clinical workflows, the question of continuous monitoring becomes urgent. Models drift, prompts change, and patient populations differ from benchmark distributions. A reference-free metric that requires no gold-standard answers and no manual annotation can, in principle, run continuously over live model outputs, flagging degradation in clinical fidelity before it reaches patients. The authors position EntQA precisely as such a framework: a scalable and interpretable way to assess clinical fidelity and reasoning quality in healthcare language models without requiring external evidence or reference standards. That combination of scalability and interpretability has been the missing piece in most prior evaluation work.

There are, of course, natural limits to what any single metric can certify. Entity retention is a necessary condition for a clinically reliable answer but arguably not a sufficient one; a model could preserve all the right concepts and still assemble them into flawed reasoning. The moderate correlation with model scale also hints that entity preservation is influenced by factors beyond raw capability, possibly including how training data distribute clinical terminology. The study’s findings, grounded in the Qwen 2.5 model family and five benchmarks, will need extension to other architectures and to open-ended clinical generation tasks beyond question answering. Still, the core result stands: an entity-centric view of evaluation correlates with what the field actually cares about, while the metrics the field has been using often do not.

The study arrives at a moment when regulators, hospitals, and model developers are all searching for trustworthy ways to evaluate medical artificial intelligence. By demonstrating that a reference-free, entity-centric metric can achieve Spearman correlations with accuracy as high as 0.9286 while conventional metrics falter, Liu and Kolachalama have offered the field a concrete alternative to benchmark-accuracy theater. If adopted broadly, the approach could shift the conversation from how often a model picks the right multiple-choice letter to whether it genuinely carries a patient’s clinical picture through its reasoning, a shift that matters far more for the safety of the patients these systems will ultimately serve.

Subject of Research: Entity-centric, reference-free evaluation of large language model responses in medical question answering

Article Title: Entity-centric evaluation of large language model responses for medical question-answering tasks

Article References: Liu, Y., & Kolachalama, V. B. (2026). Entity-centric evaluation of large language model responses for medical question-answering tasks. PLOS Digital Health, 5(10), e0001752. https://doi.org/10.1371/journal.pdig.0001752

Image Credits: AI Generated

DOI: 10.1371/journal.pdig.0001752

Keywords: large language models, medical question answering, EntQA, clinical evaluation, natural language processing, biomedical entities, reference-free metrics, healthcare AI, Qwen 2.5, benchmark evaluation, clinical fidelity, model scaling

The breadth of the evidence base matters for a practical reason. Regulatory frameworks for software have historically been written after technologies have already proliferated, forcing agencies to retrofit oversight onto systems that were never designed with scrutiny in mind. By consulting patients and clinicians alongside developers and international experts before finalizing its recommendations, the commission has attempted to invert that pattern. The resulting document, as characterized in the JMIR article, is being described as one of the most ambitious regulatory rethinks of AI in health care undertaken by any national health system to date, a claim that reflects both the scope of the recommendations and the breadth of input behind them.

Three main themes emerge from the 44 recommendations, according to Athni’s analysis. The first is life cycle regulation, the idea that oversight of a medical AI system should not end the moment it receives authorization but should continue across its entire operational existence. This is a significant departure from traditional device regulation, which has tended to treat approval as a gate at the beginning of a product’s life. Machine learning systems are different: their behavior can drift as they encounter new patient populations, new data distributions, or updated model versions, and a regulator that only evaluates a frozen snapshot of the software risks certifying a system that no longer exists in the wild.

A central mechanism proposed for life cycle oversight is what the report calls a Master File system, under which developers of general-purpose AI models would share technical details confidentially with regulators. The concept addresses one of the thorniest problems in AI governance: the tension between transparency and commercial secrecy. Developers are often unwilling to publish model architectures, training data summaries, or fine-tuning procedures, both for competitive reasons and because full public disclosure can create security risks. A confidential Master File offers a middle path, giving regulators the technical depth they need to assess safety while keeping sensitive information out of the public domain. General-purpose models, the large foundation models increasingly adapted for clinical tasks, pose particular challenges here because a single underlying system may be repurposed for many downstream medical applications, each of which may inherit strengths and weaknesses from the base model in ways that individual product reviews cannot easily capture.

The second theme identified in the JMIR analysis is the distribution of responsibility for AI safety across multiple stakeholders. This reflects a growing recognition that no single actor, not the developer, not the hospital, not the regulator, can guarantee safe deployment alone. A diagnostic algorithm may be well built and well validated, yet still cause harm if it is deployed in a population it was never tested on, if clinicians are not trained to interpret its outputs, or if local workflows encourage over-reliance on its predictions. Spreading accountability across the ecosystem is intended to close those gaps, ensuring that someone is responsible at each stage from design and validation through procurement, integration, day-to-day clinical use, and post-market surveillance.

The third theme centers on patients themselves. The commission recommends establishing pathways for patients to access information about how AI is used in their care and to raise concerns when they believe something has gone wrong. This is more than a courtesy. Public trust is widely regarded as a prerequisite for the adoption of AI in health care, and trust is difficult to sustain if patients cannot find out when an algorithm influenced their diagnosis or treatment, or if they have no clear channel for reporting perceived harms. Concern reporting also serves a technical function: patient and clinician reports are a valuable source of post-market safety data, surfacing failure modes that pre-deployment testing cannot anticipate.

Beyond these three themes, the report recommends expanding the MHRA’s AI Airlock program, described in the JMIR article as a regulatory sandbox where manufacturers and regulators can test new AI tools together before full authorization. Sandboxes have become an increasingly popular instrument in technology regulation because they allow controlled experimentation. For AI medical devices, the value is considerable: developers can gather real-world evidence on performance and safety under regulatory supervision, while regulators gain hands-on familiarity with novel technologies before deciding how to authorize them. This iterative, evidence-generating approach is better matched to the uncertainties of machine learning systems than a simple pass-fail approval process, and it can shorten the path to market for tools that demonstrate safety while filtering out those that do not.

Cybersecurity receives its own explicit attention in the recommendations. The commission proposes issuing clear cybersecurity guidance, built into AI devices from the design stage, along with tailored rules for consumer health apps and wearables. The urgency of this is not abstract. Health systems that integrate AI deeply into diagnosis, triage, and treatment become attractive targets for cyberattacks, and a successful intrusion into an AI-dependent clinical pathway could disrupt care at scale in ways that a compromised traditional device might not. The principle of building security in from the design stage, rather than bolting it on afterward, mirrors long-standing practice in safety-critical software engineering and acknowledges that retrofitting security onto deployed AI systems is far harder and less reliable. The separate attention given to consumer health apps and wearables reflects a regulatory gap: many of these products fall outside traditional medical device categories, yet they collect sensitive health data and increasingly feed information into clinical decision-making.

Taken together, the recommendations sketch a regulatory philosophy that differs meaningfully from earlier approaches to medical software. Where previous frameworks emphasized a single authorization decision, the UK blueprint emphasizes continuous oversight, shared responsibility, confidentiality-protected technical review, pre-authorization experimentation, security by design, and patient-facing transparency. Each element responds to a specific technical characteristic of modern AI: model drift motivates life cycle regulation; the opacity and generality of foundation models motivate the Master File; the distributed nature of deployment motivates multi-stakeholder accountability; uncertainty about real-world performance motivates the AI Airlock; the connectivity of AI systems motivates security-by-design guidance; and the dependence of AI safety on trust motivates patient access and concern pathways.

The implications extend well beyond Britain’s borders. Regulatory frameworks for AI in health care are still fragmentary in much of the world, and national health systems are watching one another closely as they experiment with governance models. A blueprint built on evidence from more than 12,000 contributors, and articulated with this level of technical specificity, is likely to be studied by regulators, developers, and health systems internationally. Whether its 44 recommendations can be implemented effectively, and whether they can keep pace with technologies that evolve faster than rulebooks, will determine whether the UK’s ambitious rethink becomes a template or a cautionary tale. For now, as the JMIR analysis concludes, it marks one of the most ambitious regulatory rethinks of AI in health care by any national health system to date, and a signal that the era of governing medical AI as an afterthought may be drawing to a close.

Subject of Research: UK regulatory framework recommendations for artificial intelligence in healthcare

Article Title: JMIR News: Analyzing the UK’s regulatory framework recommendations for healthcare AI

Article References: JMIR News: Analyzing the UK’s regulatory framework recommendations for healthcare AI. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: healthcare AI, regulation, MHRA, United Kingdom, life cycle regulation, Master File, AI Airlock, regulatory sandbox, cybersecurity, patient safety, medical devices, health policy

At the heart of the vision is a continuous operational cycle the authors describe as Perceive, Reason, Act, and Learn. In this model, a perception module continuously gathers data from the environment through sensors, data streams, or other digital inputs. A cognition layer then analyzes this information, drawing on reasoning mechanisms that may combine symbolic logic, probabilistic inference, and deep neural representations. A decision-making component selects actions aligned with the agent’s objectives, constraints, and context, and feedback loops allow the system to refine its strategies as tasks unfold. Unlike automated scripts that follow fixed instructions, agents in this framework are entities with planned behavior, prioritization, and adaptation, capable of pursuing goals that are either preprogrammed or self-generated without continued human supervision.

The architecture proposed by the team is deliberately layered. At its core sits a large language model serving as the reasoning engine, surrounded by four functional modules covering planning, memory, tools, and action. Around these sit multi-agent scaling patterns, ranging from single agents to distributed, hierarchical, and orchestrated deployments, and finally the external interfaces that connect agents to users, APIs, data sources, cloud platforms, knowledge bases, and the web. Planning infrastructure breaks high-level objectives into practical subtasks, often using reinforcement learning or model-based planning, while memory components store short-term context and retain long-term knowledge. Policy layers enforce operational rules and boundaries. The authors stress that this holistic design is intended to solve a critical problem in the field: the isolated development of components that were never designed to work together.

That isolation problem runs deep. Modern large language models are trained predominantly on publicly available internet content, which gives them broad but shallow competence. When applied to real-world domains such as healthcare, transport, or industrial automation, they often fail to identify domain knowledge, dynamically evolving contextual signals, and operational constraints. The authors call this the jack-of-all-trades but master-of-none effect: generalist models provide a wide base of knowledge but lack depth in any particular area unless they are adapted, fine-tuned, or integrated with external resources and structured databases. Retrieval-augmented generation can mitigate some of these weaknesses by grounding outputs in external information, but only if the retrieval itself is reliable, and it adds computational overhead that strains infrastructure.

Hallucination remains perhaps the most stubborn technical defect. The paper notes that state-of-the-art systems struggle with hallucinations in their core language models, a problem rooted in pre-training restrictions and post-training behavior in which models deliver confident outputs even under ambiguity. The issue is compounded by a training-deployment misalignment: models are typically trained on limited, task-focused datasets rather than actual operational conditions, so performance degrades when the practical environment differs from the training setup. In an autonomous agent, such errors do not merely produce a wrong answer; they can cascade into harmful actions with unclear accountability for who is responsible, raising difficult questions of safety, trust, and ethics.

Scaling introduces its own failure modes. When multiple agents operate within shared environments, their interactions can produce emergent system-level behaviors that are not explicitly programmed but arise from collective dynamics, a hallmark of complex systems. While emergence can be powerful, it also invites coordination failures across distributed systems, and the authors observe that learning methods such as reinforcement, meta-learning, and transfer learning have been developed separately from scaling approaches that move from single-agent to multi-agent configurations, with no common standard for deploying them across different fields. High-level reasoning, planning, and learning operations are also computationally and energy intensive, making them practically unsuitable for real-time, large-scale tasks such as smart city management, and performance decay is observed as the number of agents or tasks grows.

Despite these caveats, the survey of applications is striking in its breadth. In healthcare, agentic AI is being used for autonomous construction and execution of medical image segmentation pipelines, real-time detection of drug-induced liver injury risks from clinical records, AI-assisted interpretation of neuromuscular electrodiagnostic tests, and personalized adaptive fitness coaching built on multimodal multi-agent digital twin systems. Future clinical assistants could integrate records, imaging, wearable devices, and genomic profiles to support continuous monitoring and early disease prediction. In transportation, agents support multimodal model predictive control for autonomous navigation and multi-agent routing optimization in logistics networks, with future systems coordinating vehicles, infrastructure, and public transit to manage congestion proactively.

The industrial and commercial reach is equally broad. In software engineering, agents automate task decomposition, tool selection, and execution with real-time feedback, and generate behavior-driven development test cases from natural language, with the long-term prospect of autonomous assistants managing the entire software lifecycle. In finance and banking, agentic systems underpin risk profiling, LLM-based financial modeling, compliance workflows, fraud detection, and personalized customer service. Smart manufacturing deploys agents for robotic assembly, supply-chain management, human-robot collaboration, and self-managing quality systems, while smart cities apply them to energy optimization, fault detection, and urban service coordination. The authors also document applications in military and security contexts, including swarm decision-making and moving-target defense, alongside multidisciplinary uses in radiology, predictive crime analytics, tourism pricing, and autonomous coding agents.

The challenges catalogued in the paper read like a checklist of everything that could go wrong. Agents may harbor biases that conflict with human values, ethics, and cultural beliefs, particularly dangerous in sensitive domains like medicine and finance. Unpredictable behavior arises from information gaps and interactions among agent components, and it is difficult to authenticate, test, and regulate agent decisions, risking failure cascades in multi-agent systems. Privacy and security risks loom because these systems handle sensitive data and are vulnerable to manipulation by malicious actors. Reliability suffers under noisy or incomplete inputs, and the lack of standardized benchmarks and evaluation methods makes impartial comparison nearly impossible, inviting exaggerated performance claims. Biased, incomplete, or outdated training data can perpetuate social inequalities, and poor coordination among agents in decentralized systems undermines both scalability and dependability.

To chart a way forward, the authors propose a six-dimensional research roadmap. It calls for trustworthy autonomous systems aligned with human values, reasoning frameworks that embed ethical principles and legal regulations, and explainable agents whose planning and decision-making can be verified by users. It urges research into decentralized communication strategies, adaptive task allocation, hierarchical coordination, and efficient collaboration protocols for large-scale multi-agent environments. Continuous adaptation through lifelong learning, meta-learning, and memory-enhanced reasoning would let agents acquire new knowledge without forgetting old lessons, while privacy-preserving techniques such as federated learning, secure multi-party computation, homomorphic encryption, and differential privacy would enable collaborative learning without exposing sensitive information. Finally, the roadmap demands standardized benchmarking datasets, evaluation metrics, testing environments, and validation protocols. The message of the paper is ultimately one of guarded optimism: agentic AI could transform healthcare, industry, cities, and governance, but only if the field abandons isolated component development and builds integrated, accountable, and rigorously evaluated systems fit for the real world.

Subject of Research: Conceptual frameworks, applications, and open challenges of autonomous agentic AI systems built on large language models

Article Title: Agentic AI: Vision and challenges

Article References: Gill, S. S., Murugesan, S. S., Anurag, K. A., Verma, P., Kaur, H., Kumar, S., & Kumar, M. (2026). Agentic AI: Vision and challenges. PLOS Complex Systems, 3(8), e0000120. https://doi.org/10.1371/journal.pcsy.0000120

Image Credits: AI Generated

DOI: 10.1371/journal.pcsy.0000120

Keywords: agentic AI, large language models, autonomous agents, hallucination, multi-agent systems, healthcare AI, smart cities, machine learning, AI ethics, scalability, retrieval-augmented generation, PLOS Complex Systems